185 related articles for article (PubMed ID: 11212230)
1. Cadmium-induced malignant transformation of human prostate epithelial cells.
Achanzar WE; Diwan BA; Liu J; Quader ST; Webber MM; Waalkes MP
Cancer Res; 2001 Jan; 61(2):455-8. PubMed ID: 11212230
[TBL] [Abstract][Full Text] [Related]
2. Cadmium-induced neoplastic transformation of human prostate epithelial cells.
Nakamura K; Yasunaga Y; Ko D; Xu LL; Moul JW; Peehl DM; Srivastava S; Rhim JS
Int J Oncol; 2002 Mar; 20(3):543-7. PubMed ID: 11836566
[TBL] [Abstract][Full Text] [Related]
3. Malignant transformation in a nontumorigenic human prostatic epithelial cell line.
Hayward SW; Wang Y; Cao M; Hom YK; Zhang B; Grossfeld GD; Sudilovsky D; Cunha GR
Cancer Res; 2001 Nov; 61(22):8135-42. PubMed ID: 11719442
[TBL] [Abstract][Full Text] [Related]
4. Altered apoptotic gene expression and acquired apoptotic resistance in cadmium-transformed human prostate epithelial cells.
Achanzar WE; Webber MM; Waalkes MP
Prostate; 2002 Aug; 52(3):236-44. PubMed ID: 12111698
[TBL] [Abstract][Full Text] [Related]
5. Malignant transformation of human benign prostate epithelial cells by high linear energy transfer alpha-particles.
Li H; Gu Y; Miki J; Hukku B; McLeod DG; Hei TK; Rhim JS
Int J Oncol; 2007 Sep; 31(3):537-44. PubMed ID: 17671680
[TBL] [Abstract][Full Text] [Related]
6. Selection of cell lines with enhanced invasive phenotype from xenografts of the human prostate cancer cell line WPE1-NB26.
Rivette AS; Tokar EJ; Williams DE; Mackenzie CD; Ablin RJ; Webber MM
J Exp Ther Oncol; 2005; 5(2):111-23. PubMed ID: 16471037
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
8. Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation.
Benbrahim-Tallaa L; Waterland RA; Styblo M; Achanzar WE; Webber MM; Waalkes MP
Toxicol Appl Pharmacol; 2005 Aug; 206(3):288-98. PubMed ID: 16039940
[TBL] [Abstract][Full Text] [Related]
9. Cadmium and prostate cancer.
Waalkes MP; Rehm S
J Toxicol Environ Health; 1994 Nov; 43(3):251-69. PubMed ID: 7966437
[TBL] [Abstract][Full Text] [Related]
10. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
Gao J; Arnold JT; Isaacs JT
Cancer Res; 2001 Jul; 61(13):5038-44. PubMed ID: 11431338
[TBL] [Abstract][Full Text] [Related]
11. Radiation-induced neoplastic transformation of human prostate epithelial cells.
Kuettel MR; Thraves PJ; Jung M; Varghese SP; Prasad SC; Rhim JS; Dritschilo A
Cancer Res; 1996 Jan; 56(1):5-10. PubMed ID: 8548774
[TBL] [Abstract][Full Text] [Related]
12. Inorganic cadmium- and arsenite-induced malignant transformation of human bladder urothelial cells.
Sens DA; Park S; Gurel V; Sens MA; Garrett SH; Somji S
Toxicol Sci; 2004 May; 79(1):56-63. PubMed ID: 14976345
[TBL] [Abstract][Full Text] [Related]
13. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide (VIP) induces malignant transformation of the human prostate epithelial cell line RWPE-1.
Fernández-Martínez AB; Bajo AM; Isabel Arenas M; Sánchez-Chapado M; Prieto JC; Carmena MJ
Cancer Lett; 2010 Dec; 299(1):11-21. PubMed ID: 20709445
[TBL] [Abstract][Full Text] [Related]
15. Malignant transformation of human prostate epithelial cells by N-nitroso-N-methylurea.
Rhim JS; Jin S; Jung M; Thraves PJ; Kuettel MR; Webber MM; Hukku B
Cancer Res; 1997 Feb; 57(4):576-80. PubMed ID: 9044828
[TBL] [Abstract][Full Text] [Related]
16. Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer.
Lubbe WJ; Zhou ZY; Fu W; Zuzga D; Schulz S; Fridman R; Muschel RJ; Waldman SA; Pitari GM
Clin Cancer Res; 2006 Mar; 12(6):1876-82. PubMed ID: 16551873
[TBL] [Abstract][Full Text] [Related]
17. A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.
London CA; Sekhon HS; Arora V; Stein DA; Iversen PL; Devi GR
Cancer Gene Ther; 2003 Nov; 10(11):823-32. PubMed ID: 14605668
[TBL] [Abstract][Full Text] [Related]
18. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.
Rocchi P; Boudouresque F; Zamora AJ; Muracciole X; Lechevallier E; Martin PM; Ouafik L
Cancer Res; 2001 Feb; 61(3):1196-206. PubMed ID: 11221851
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
Song K; Cornelius SC; Danielpour D
Cancer Res; 2003 Aug; 63(15):4358-67. PubMed ID: 12907605
[TBL] [Abstract][Full Text] [Related]
20. Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression.
Webber MM; Quader ST; Kleinman HK; Bello-DeOcampo D; Storto PD; Bice G; DeMendonca-Calaca W; Williams DE
Prostate; 2001 Apr; 47(1):1-13. PubMed ID: 11304724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
